The protective impact of fish consumption on GC incidence has been evaluated in 17 epidemiological studies,

but there was no documented protective effect (RR 0.87; 95% CI 0.71–1.07) [19]. In a further study, a synergistic effect of carcinogenic agents like salt, tobacco, and meat was found in the context of a H. pylori infection. selleck products Furthermore, the protective effect of natural antioxidants was more evident in patients that were H. pylori positive [20]. A Cochrane analysis of 55 trials with 5261 patients analyzed the effect of traditional Chinese herbal medicine on the outcome of patients treated with systemic chemotherapy. This meta-analysis suffers from a high heterogeneity. Some trials reported improvement in mortality, some improvement in quality of life, and other better remission rates [21]. Different types of physical activity and the risk of esophageal adenocarcinoma and GC were assessed as further aspects in the European EPIC trial [22]. A total of 4,20,449 participants from nine European countries were followed, and increasing levels of physical activity were associated with a lower risk of overall and especially noncardia GC with increasing levels of physical activity (GC: HR 0.69, 95% CI 0.50–0.94; noncardia GC 0.44, 95% CI 0.26–0.74). There was neither an effect on cardia cancer or adenocarcinomas of the esophagus, nor any influence by different Laurén types of GC PF-01367338 price [22]. In a recent meta-analysis,

a pooled risk reduction for gastric carcinogenesis was related to acetylsalicylic acid (ASA) intake if only randomized controlled trials were considered (OR 0.72; 95% CI 0.62–0.84) [23]. The protective effect of ASA was best in noncardia GC (OR 0.62; 95% CI 0.55–0.69) click here and H. pylori-positive individuals (OR 0.62; 95% CI 0.42–0.90). A large pooled analysis on the influence of ASA intake on cancer death from the UK (eight trials, 25,570 patients, and 674 cancer-related

deaths) showed a reduction in cancer-related death in association with ASA intake (OR 0.79; 95% CI 0.68–0.92) [24]. In GC, a beneficial effect was seen only in the follow-up period of 10–20 years (HR of 0.42; 95% CI 0.23–0.79). The beneficial effect was generally increased in relation to the duration of treatment. In a nationwide retrospective cohort study from Taiwan on more than 52,000 patients with the primary diagnosis of peptic ulcer, the group “never NSAIDs” had a significantly higher risk for GC when compared with the general population (standardized incidence ratio – SIR 2.11; 95% CI 2.07–2.15). The group “regular NSAIDs” had a decreased risk (SIR 0.79, 95% CI 0.77–0.81). Nonsteroidal anti-inflammatory drug (NSAID) use was confirmed as protective factor against GC development in the multivariate analysis with a number needed to treat 50 H. pylori-positive patients. The positive effect of NSAID intake was also reported in a recent meta-analysis with an adjusted RR of 0.81 (95% CI 0.73–0.89) [25]. In a study on 157 patients with GC from China, prevalence of H.